Anaplastic Large Cell Lymphoma

• CLINICAL_TRIALS withdrawal · 2025-06-12
  Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]

  A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaqu…

• CLINICAL_TRIALS withdrawal · 2023-02-21
  Clinical Trial Update: CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) [Phase 2, Phase 3]

  Clinical trial CELTIC-1 evaluating cerdulatinib in relapsed/refractory peripheral T-cell lymphoma has been withdrawn from the study.

• CLINICAL_TRIALS withdrawal · 2016-02-03
  Clinical Trial Update: Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma [Phase 2]

  Phase 2 trial evaluating a chemotherapy regimen followed by Rituximab and Yttrium-90 ibritumomab tiuxetan for AIDS-related Non-Hodgkin lymph…

• CLINICAL_TRIALS withdrawal · 2013-05-15
  Clinical Trial Update: Denileukine Diftitox for Relapsed ALCL [Phase 2]

  A Phase 2 trial evaluating denileukin diftitox (Ontak) for relapsed Anaplastic Large-Cell Lymphoma has been withdrawn. The study sponsor is …

• CLINICAL_TRIALS withdrawal · 2010-04-26
  Clinical Trial Update: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma [Phase 2]

  This Phase 2 trial evaluating MDX-060 in relapsed or refractory anaplastic large cell lymphoma (systemic and primary cutaneous) has been wit…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.